Ascent Group, LLC Laboratory Corp Of America Holdings Transaction History

Ascent Group, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$197.69 - $227.29 $22,932 - $26,365	116 Added 3.31%	3,618 $822,000
Q3 2023 Nov 14, 2023	BUY	$201.05 - $221.7 $483,927 - $533,631	2,407 Added 219.82%	3,502 $704,000
Q2 2023 Aug 14, 2023	SELL	$211.93 - $241.33 $46,412 - $52,851	-219 Reduced 16.67%	1,095 $264,000
Q1 2023 May 10, 2023	SELL	$213.32 - $257.83 $19,838 - $23,978	-93 Reduced 6.61%	1,314 $301,000
Q4 2022 Feb 16, 2023	SELL	$203.72 - $248.97 $97,378 - $119,007	-478 Reduced 25.36%	1,407 $331,000
Q3 2022 Nov 14, 2022	SELL	$204.81 - $262.19 $192,521 - $246,458	-940 Reduced 33.27%	1,885 $418,000
Q2 2022 Aug 05, 2022	SELL	$213.86 - $277.87 $276,307 - $359,008	-1,292 Reduced 31.38%	2,825 $741,000
Q1 2022 May 10, 2022	BUY	$259.82 - $298.18 $50,145 - $57,548	193 Added 4.92%	4,117 $1.09 Million
Q4 2021 Mar 01, 2022	BUY	$271.6 - $314.21 $1.07 Million - $1.23 Million	3,924 New	3,924 $1.07 Million

1.94M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $21.7B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of Ascent Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Ascent Group, LLC with notifications on news.